Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Iot symbols : GSK save search
IoT In Healthcare Market Size Growing at 19.20 % CAGR, Set to Reach USD 388.18 Billion by 2027 says Brandessence Market Research
Published: 2023-04-04 (Crawled : 09:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 2.17%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.43%
H: 0.27%
C: 0.27%
CBDS 4 | $0.0163 -28.22% 90K
|
Manufacturing
|
| O: 0.0%
H: 0.0%
C: -9.09%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.13%
H: 1.03%
C: 0.91%
MDT | $79.48 0.37% -0.29% 6.7M
|
Health Technology
|
| O: 0.23%
H: 0.63%
C: -0.48%
PHG | $19.98 0.0% 540K
|
Health Technology
|
| O: -0.82%
H: 1.57%
C: 1.05%
IBM | News | $181.58 0.06% -0.32% 3M
|
Technology Services
|
| O: -0.05%
H: 0.12%
C: -0.3%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.64%
H: 1.11%
C: 1.02%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: 0.31%
H: 1.41%
C: 0.88%
QCOM | $157.65 -2.35% -2.4% 10M
|
Electronic Technology
|
| O: 0.15%
H: 0.23%
C: -2.11%
MSFT | News F | $399.09 -1.28% -1.3% 29M
|
Technology Services
|
| O: 0.0%
H: 1.12%
C: -0.02%
AAPL | News S | $164.96 -1.24% -1.32% 67M
|
Electronic Technology
|
| O: 0.26%
H: 0.15%
C: -0.58%
iot research growing set market
Marker Therapeutics Appoints Biotech Executive Katharine Knobil, M.D., to Board of Directors
Published: 2021-12-09 (Crawled : 12:30) - biospace.com/
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.68%
H: 0.08%
C: -0.23%
A | $132.73 0.22% 0.0% 1.3M
|
Health Technology
|
| O: 1.16%
H: 0.96%
C: -1.21%
MRKR | $4.25 3.65% 3.52% 15K
|
Consumer Services
|
| O: 8.11%
H: 2.5%
C: -3.33%
therapeutics biotech iot
GSK and Vir Biotechnology Announce United States Government Agreements to Purchase Sotrovimab, a COVID-19 Treatment
Published: 2021-11-17 (Crawled : 12:00) - globenewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.43%
H: 2.31%
C: 2.27%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.28%
H: 0.0%
C: 0.0%
VIR | $7.96 0.0% 1.1M
|
Health Technology
|
| O: 9.97%
H: 4.0%
C: -6.28%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
covid treatment biotech technology iot covid-19
Celiac Diseases Drugs Market Report Featuring Major Vendors including Amgen Inc., AMYRA Biotech AG & BioLineRx Ltd. | Discover Company Insights in Technavio
Published: 2021-09-06 (Crawled : 08:00) - prnewswire.com
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
| Email alert
Add to watchlist
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
| Email alert
Add to watchlist
BLRX | $0.6564 2.55% 2.48% 190K
|
Health Technology
| Email alert
Add to watchlist
disease biotech drug iot
GSK and Vir Biotechnology Announce Joint Procurement Agreement with European Commission for COVID-19 Treatment, Sotrovimab
Published: 2021-07-28 (Crawled : 12:00) - biospace.com/
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -1.06%
H: 1.31%
C: 1.02%
VIR | $7.96 0.0% 1.1M
|
Health Technology
|
| O: 1.54%
H: 4.68%
C: 0.14%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.5%
H: 1.7%
C: 1.4%
covid treatment europe biotech technology iot covid-19
Global Nanobiotechnology Applications and Markets 2021-2026: Molecular Diagnostic, Therapeutics, & Biopharmaceutical Application
Published: 2021-07-27 (Crawled : 20:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.04%
H: 0.38%
C: -0.32%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -1.06%
H: 1.31%
C: 1.02%
AVDL | $17.33 -0.29% -0.29% 1.3M
|
Health Technology
|
| O: -0.88%
H: 1.89%
C: -1.51%
biopharma molecular biotech technology iot application diagnostic
Biodefense Market Growth Analysis in Biotechnology Industry | Technavio
Published: 2021-07-08 (Crawled : 04:00) - prnewswire.com
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.89%
H: 0.35%
C: 0.23%
defense biotech growth technology iot market
Elliott Publishes Letter on GlaxoSmithKline
Published: 2021-07-01 (Crawled : 07:00) - prnewswire.com
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.35%
H: 1.18%
C: 0.53%
iot
GSK and Vir Biotechnology Announce Continuing Progress of the COMET Clinical Development Program for Sotrovimab
Published: 2021-06-21 (Crawled : 12:00) - biospace.com/
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.15%
H: 0.33%
C: 0.0%
VIR | $7.96 0.0% 1.1M
|
Health Technology
|
| O: 0.5%
H: 6.27%
C: 5.89%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.32%
H: 0.17%
C: -0.13%
ev biotech technology iot
Global Travel Vaccines Market to witness $ 2.23 Bn growth during 2021-2025 | Bharat Biotech Ltd., CSL Ltd., and GlaxoSmithKline Plc to emerge as major players | Technavio
Published: 2021-06-11 (Crawled : 11:00) - prnewswire.com
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.05%
H: 0.12%
C: -0.25%
travel biotech vaccine growth iot merge
GSK and Vir Biotechnology Announce Sotrovimab (VIR-7831) Receives Emergency Use Authorization from the US FDA for Treatment of Mild-to-Moderate COVID-19 in High-Risk Adults and Pediatric Patients
Published: 2021-05-26 (Crawled : 23:00) - globenewswire.com
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.8%
H: 0.69%
C: 0.23%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.17%
H: 0.36%
C: -0.72%
VIR | $7.96 0.0% 1.1M
|
Health Technology
|
| O: 4.2%
H: 0.3%
C: -9.4%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.5%
H: 0.32%
C: -1.27%
covid treatment fda risk biotech technology iot merge authorized emergency use authorization
CORRECTION -- EMA Issues Positive Scientific Opinion on GSK and Vir Biotechnology’s Sotrovimab For the Early Treatment of COVID-19
Published: 2021-05-21 (Crawled : 14:00) - globenewswire.com
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.26%
H: 0.26%
C: -0.21%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.24%
H: 0.96%
C: -0.06%
VIR | $7.96 0.0% 1.1M
|
Health Technology
|
| O: 1.75%
H: 0.13%
C: -1.44%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.43%
H: 0.2%
C: 0.02%
covid treatment positive biotech technology iot ema
EMA Issues Positive Scientific Opinion on GSK and Vir Biotechnology’s Sotrovimab For the Early Treatment of COVID-19
Published: 2021-05-21 (Crawled : 12:15) - globenewswire.com
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.26%
H: 0.26%
C: -0.21%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.24%
H: 0.96%
C: -0.06%
VIR | $7.96 0.0% 1.1M
|
Health Technology
|
| O: 1.75%
H: 0.13%
C: -1.44%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.43%
H: 0.2%
C: 0.02%
covid treatment positive biotech technology iot ema
GSK and Vir Biotechnology Announce the Start of the EMA Rolling Review of VIR-7831 (sotrovimab) for the Early Treatment of COVID-19
Published: 2021-05-07 (Crawled : 14:00) - biospace.com/
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.5%
H: 0.84%
C: 0.66%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.48%
H: 0.74%
C: 0.31%
VIR | $7.96 0.0% 1.1M
|
Health Technology
|
| O: 3.24%
H: 2.94%
C: 0.02%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.92%
H: 0.88%
C: 0.66%
covid treatment biotech technology iot ema
GSK and Vir Biotechnology Announce EMA Review of Dual-Action Monoclonal Antibody VIR-7831 for the Early Treatment of COVID-19
Published: 2021-04-15 (Crawled : 14:00) - globenewswire.com
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 4.23%
H: 1.59%
C: 0.08%
VIR | $7.96 0.0% 1.1M
|
Health Technology
|
| O: 0.37%
H: 2.8%
C: -1.49%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.76%
H: 0.61%
C: 0.14%
covid treatment antibody biotech technology iot ema
Lilly, Vir Biotechnology and GSK Announce Positive Topline Data from the Phase 2 BLAZE-4 Trial Evaluating Bamlanivimab with VIR-7831 in Low-Risk Adults with COVID-19
Published: 2021-03-29 (Crawled : 14:00) - biospace.com/
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.82%
H: 1.18%
C: 0.88%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.35%
H: 1.63%
C: 0.91%
VIR | $7.96 0.0% 1.1M
|
Health Technology
|
| O: -1.46%
H: 1.02%
C: -4.73%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.56%
H: 0.83%
C: 0.57%
covid phase 2 risk positive topline biotech technology iot trial
GSK and Vir Biotechnology Announce Submission of Emergency Use Authorization Request to FDA for VIR-7831 for the Early Treatment of COVID-19
Published: 2021-03-26 (Crawled : 13:00) - globenewswire.com
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.28%
H: 2.0%
C: 1.95%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.52%
H: 1.01%
C: 0.68%
VIR | $7.96 0.0% 1.1M
|
Health Technology
|
| O: 1.27%
H: 1.56%
C: -3.45%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.31%
H: 1.33%
C: 1.22%
covid treatment fda biotech technology iot merge submission authorized emergency use authorization
Vir Biotechnology and GSK Announce VIR-7831 Reduces Hospitalization and Risk of Death in Early Treatment of Adults with COVID-19
Published: 2021-03-11 (Crawled : 02:00) - globenewswire.com
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.67%
H: 0.96%
C: 0.54%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.52%
H: 0.36%
C: -0.63%
VIR | $7.96 0.0% 1.1M
|
Health Technology
|
| O: 44.57%
H: 0.75%
C: -8.66%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.31%
H: 0.63%
C: 0.08%
covid treatment risk biotech iot
Vir Biotechnology and GSK Provide Update on NIH-Sponsored ACTIV-3 Trial Evaluating VIR-7831 in Hospitalized Adults with COVID-19
Published: 2021-03-03 (Crawled : 15:00) - biospace.com/
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.26%
H: 0.93%
C: 0.71%
VIR | $7.96 0.0% 1.1M
|
Health Technology
|
| O: -28.99%
H: 8.39%
C: 1.9%
covid biotech iot trial
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.